Blog Header

In: Outsourcing

18 Feb, 2014Computational Drug Discovery: Traditional Methods Aren’t Enough!


Traditional drug discovery is expensive, inefficient, and has huge barriers to entry. Big pharmaceutical companies continue to struggle to cope with tight margins…

Read More

23 Jan, 20143 Ways to Avoid Drowning in Big Data


This is the third in a three-part series by Dr. Heather Buschman on Big Data in the pharmaceutical and biotechnology industries. Check out…

Read More

31 Dec, 2013CNS Therapeutics: Restrategizing Pharmaceutical Development


The need for CNS therapeutics is on the rise.  Neurological diseases are expected to increase steadily in the coming years.  Previously, we addressed…

Read More

12 Nov, 2013Key factors in CRO selection Part 3: Evaluating CROs – company insights


Use of CROs in research and drug development in increasing.  ADDF shared their recommendations for navigating CRO selection 1.  We’ve summarized their insights…

Read More

07 Nov, 2013Key Factors in CRO Selection Part 2: Program Oversight


Contract research organizations (CROs) often have experience overseeing all aspects of a drug development program.  ADDF recently shared their insights on navigating CRO…

Read More